Synopsis
CEST imaging has numerous applications, but its widespread clinical use
is hampered by relatively long acquisition times. Here, a novel
variably-accelerated sensitivity encoding (vSENSE) method is proposed that
provides faster CEST acquisitions than conventional SENSE. The vSENSE approach undersamples k-space
variably for images acquired at different saturation frequencies to maximize
acquisition speed. vSENSE was validated in a phantom and in 8 patients with brain tumors studied at
3T. The vSENSE method provided a 4-fold acceleration, compared to conventional
SENSE which permitted only a 2-fold acceleration, with both compared to a full
k-space reconstruction.Purpose
The routine
clinical application of CEST MRI is limited by its relatively long scan times,
since CEST typically requires images to be repeat acquisitions with different
saturation frequencies. Despite recent advances in fast CEST acquisition
methods (1-4), the only widespread option available on MRI scanners for
accelerating CEST acquisitions, is currently parallel imaging, such as with SENSE
(5). However, the acceleration factor
offered by SENSE for CEST MRI rarely goes beyond two (6-8).
Here, a novel acquisition and reconstruction method, variably-accelerated
sensitivity encoding (vSENSE), is proposed for faster acquisition than conventional
SENSE. The vSENSE method undersamples k-space variably for
images acquired at different saturation frequencies to generate accurate
sensitivity maps and maximize acquisition speed.
Methods
The vSENSE method was validated on a doped
water phantom and 8 consented brain tumor patients studied on a 3T Philips MRI scanner
with a 32-channel head coil. CEST contrast was achieved using 0.8s saturation
duration and 2μT saturation power (saturation frequencies, 14 to -8ppm stepped
at 0.5ppm, in addition to an unsaturated reference–S0; two-dimensional
turbo-spin-echo, TSE, for image readout; FOV=212×185×4.4mm; acquisition
resolution=2.2×2.2×4.4mm; acquisition matrix size=96×84x1; total duration=2.7min)
(6). A 2D TSE “WASSR” (9) sequence was acquired separately for B0 inhomogeneity
correction. The raw k-space CEST data and the vendor’s preset sensitivity
reference scan, were saved for offline in-house reconstruction. Conventional T2-weighted,
FLAIR, and T1-weighted anatomical MRI were also acquired from each
patient.
First, standard reconstruction was performed
with the following steps: (A1) Fourier transforming (FT) the k-space data from
each channel; and (A2) combining images from all channels using the “maximized
SNR” strategy (10).
Second, SENSE reconstruction was performed by: (B1)
computing sensitivity maps from the vendor’s preset reference scan; (B2) undersampling
by increasing the phase-encoding gradient step size by 4-fold in every dynamic
CEST dataset, resulting in folded images; and (B3) reconstructing unfolded
images using the SENSE method (5).
Third, vSENSE reconstruction was performed by: (C1)
selecting one of the CEST dynamic images to retain the full k-space data (acceleration,
R=1). Here the S0 dynamic was chosen. (C2) Reconstruct images from this
fully acquired data set using FT, and fit the sensitivity maps with a weighted
polynomial. (C3) Increase the phase-encoding gradient step size to variably
undersample the other CEST images, with R=2 for the ±3.5ppm images and R=4 for
the rest. (C4) Apply the estimated sensitivity maps to the variably
undersampled datasets to reconstruct images.
Results and
Discussion
Fig. 1 shows the conventional SENSE image (Fig.
1b, R=4) has a much greater difference (Fig. 1d) from the standard FT image (Fig.
1a, R=1), compared to the difference (Fig. 1e) with the vSENSE method (Fig. 1c,
R=4). The vSENSE method self-estimates the sensitivity maps from the fully-acquired
S0 dynamic, resulting in more accurate estimation of sensitivity
maps than conventional SENSE with a separate reference sensitivity scan. This
is because the vendor’s preset SENSE reference scan acquired at the beginning
of each exam virtually always uses a different acquisition sequence, resolution
and orientation vs. subsequent imaging scans.
Fig. 2 from a brain tumor patient, shows
conventional SENSE (R=4) yielded substantially corrupted Amide Proton Transfer (11) weighted (APTw, part e) and raw (part g) images, compared to the
standard FT results (blue arrows indicate tumor region, and red arrows indicate
SENSE-reconstruction artifacts). In contrast, the vSENSE (R=4) method generated
APTw (part f) and raw (part h) images, as well as z-spectra (part i) highly
consistent with FT ones. Note that the sampling pattern can be adapted for other
CEST imaging applications, such as creatine (12) or glucose(13, 14) imaging.
Conclusion
The vSENSE method variably undersamples saturated
images at different frequencies, resulting in an overall acceleration factor of
essentially four. In conjunction with the fully-sampled S
0 dynamic,
the vSENSE method guarantees accurate sensitivity maps and sufficient SNR for
accurate APTw imaging. As implemented here, vSENSE doubled the speed and provided better results than
conventional SENSE, which may prove key for advancing CEST to the clinic.
Acknowledgements
Funding Support:
NIH Grant R01 EB007829, CA166171, EB009731, NS083435References
1. Xu X, Lee JS, Jerschow A. Ultrafast
scanning of exchangeable sites by NMR spectroscopy. Angewandte Chemie
International Edition. 2013;52(32):8281-4.
2. Döpfert J, Zaiss M, Witte C, Schröder
L. Ultrafast CEST imaging. J Magn Reson. 2014;243:47-53.
3. Varma G, Lenkinski R, Vinogradov E.
Keyhole chemical exchange saturation transfer. Magn Reson Med.
2012;68(4):1228-33.
4. Zhang Y, Heo HY, Jiang S, Lee DH,
Bottomley PA, Zhou J. Highly accelerated chemical exchange saturation transfer
(CEST) measurements with linear algebraic modeling. Magn Reson Med. 2015. doi:
10.1002/mrm.25873.
5. Pruessmann KP, Weiger M, Scheidegger
MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med.
1999;42(5):952-62.
6. Zhu H, Jones CK, van Zijl P, Barker PB,
Zhou J. Fast 3D chemical exchange saturation transfer (CEST) imaging of the
human brain. Magn Reson Med. 2010;64(3):638-44.
7. Zhou J, Zhu H, Lim M, Blair L, Quinones-Hinojosa A, Messina SA, Eberhart
CG, Pomper MG, Laterra J, Barker PB. Three-dimensional amide proton transfer MR
imaging of gliomas: Initial experience and comparison with gadolinium
enhancement. J Magn Reson Imaging. 2013;38(5):1119-28.
8. Zhao X, Wen Z, Zhang G, Huang F, Lu S,
Wang X, Hu S, Chen M, Zhou J. Three-dimensional turbo-spin-echo amide proton
transfer MR imaging at 3-Tesla and its application to high-grade human brain
tumors. Mol Imaging Biol. 2013;15(1):114-22.
9. Kim M, Gillen J, Landman BA, Zhou J,
van Zijl P. Water saturation shift referencing (WASSR) for chemical exchange
saturation transfer (CEST) experiments. Magn Reson Med. 2009;61(6):1441-50.
10. Roemer P,
Edelstein W, Hayes C, Souza S, Mueller O. The NMR phased array. Magn Reson Med.
1990;16(2):192-225.
11. Zhou J, Payen
J-F, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of
intracellular proteins and peptides to detect pH effects in MRI. Nat Med.
2003;9(8):1085-90.
12. Haris M, Singh
A, Cai K, Kogan F, McGarvey J, DeBrosse C, Zsido GA, Witschey WR, Koomalsingh
K, Pilla JJ. A technique for in vivo mapping of myocardial creatine kinase
metabolism. Nat Med. 2014;20(2):209-14.
13. Chan KW,
McMahon MT, Kato Y, Liu G, Bulte JW, Bhujwalla ZM, Artemov D, van Zijl P.
Natural D-glucose as a
biodegradable MRI contrast agent for detecting cancer. Magn Reson Med.
2012;68(6):1764-73.
14. Walker-Samuel
S, Ramasawmy R, Torrealdea F, Rega M, Rajkumar V, Johnson SP, Richardson S,
Gonçalves M, Parkes HG, Årstad E. In vivo imaging of glucose uptake and
metabolism in tumors. Nat Med. 2013;19(8):1067-72